Overview | Agenda | Faculty Materials | Administration | Contact Us | Order CDs
Registration | Privacy Policy | Past Audioconferences | Audioconference Home






National Disclosure Audioconference: Analysis of the Revised Physician Payments Sunshine Act and State Drug Marketing Laws

Tuesday, February 10, 2009

  • 1:00 pm - 2:30 pm (Eastern)
  • 12:00 pm - 1:30 pm (Central)
  • 11:00 am - 12:30 pm (Mountain)
  • 10:00 am - 11:30 am (Pacific)
AUDIOCONFERENCE FACULTY

Christopher J. Armstrong, Esq.
Investigative Counsel, Committee on Finance, The Honorable Chuck Grassley, Ranking Member, United States Senate, Washington, DC

John T. Bentivoglio, Esq.
Partner, King & Spalding LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, Department of Justice, Washington, DC

Jennifer Colapietro
Director, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers LLC, Florham Park, NJ

Sharon Anglin Treat, Esq.
Maine State Representative, Executive Director, NLARx, Augusta, ME

Brian Riewerts
Partner, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP, Washington, DC (Moderator)


AUDIOCONFERENCE OVERVIEW

Senators Charles Grassley and Herb Kohl introduced a revised version of the Physician Payments Sunshine Act January 23, 2009. On Tuesday, February 10, Chris Armstrong, Senator Grassley's key aide on this important issue, will brief the industry on the latest version of the Sunshine Act and what it means for drug and device companies.

Also joining the 90-minute panel discussion will be Maine State Rep. Sharon Treat, a leading activist in the development of state marketing requirements for drug and device companies. Treat, who chairs NLARx, will review the ambitious agenda of state legislators regarding disclosure requirements and other key initiatives.

Expert advice on proactive steps drug and device companies can take to prepare for the complex task of disclosing physician payments will be offered by former DOJ attorney John Bentivoglio and Jennifer Colapietro of PricewaterhouseCoopers. The panel will be moderated by PWC's Brian Riewerts.


AUDIOCONFERENCE AGENDA
The Audioconference agenda is set forth in Eastern Daylight Time below:
1:00 pm Welcome and Introductory Comments
Brian Riewerts (Moderator)
1:05 pm Where we are Today on State and Federal Disclosure, Transparency and Aggregate Spend Policy
Jennifer Colapietro
1:20 pm Overview if the Proposed Federal Sunshine Act
Christopher J. Armstrong, Esq.
1:35 pm Update from the States
Sharon Anglin Treat, Esq.
1:50 pm The Disclosure Implications of Recent Settlements and CIAs
John T. Bentivoglio, Esq.
2:05 pm Questions and Answers
Brian Riewerts (Moderator)
2:30 pm Audioconference Adjournment

SAVE THE DATE
FIRST ANNUAL SUMMIT ON DISCLOSURE FOR DRUG, DEVICE AND BIOTECH COMPANIES
A Hybrid Conference, Internet Event and Training Tool
March 5 - 6, 2009
Renaissance Washington DC Hotel
Washington, DC
www.DisclosureSummit.com


SENATORS GRASSLEY AND KOHL INTRODUCE REVISED VERSION OF PHYSICIAN SUNSHINE ACT
1/22/2009

Senators Charles Grassley and Herb Kohl introduced a revised version of the Physician Payments Sunshine Act January 22, 2009. The new bill effectively eliminates the preemption of state laws, which had been the cornerstone of the industry's support for the measure. It also reduces the threshold for drug and device companies to publicly report payments to physicians from $500 a year to $100 a year, another major blow from the industry's standpoint. All sides expect a contentious debate as Congress considers the measure.

SPONSORED BY:











This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.




Overview | Agenda | Faculty Materials | Administration | Contact Us | Order CDs
Registration | Privacy Policy | Past Audioconferences | Audioconference Home




© Health Care Conference Administrators
Contact Webmaster